Access cutting-edge neoplasm malignant treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Brunswick location
Preparing your pre-screening questions…
Access neoplasm malignant specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neoplasm malignant treatment provided free
Check if you qualify for this neoplasm malignant clinical trial in New Brunswick, NJ
No-Cost Study Care
Local to New Brunswick
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Researchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many people have the cancer respond (get smaller or go away) to calderasib alone or with cetuximab and how these responses compare * About the safety of calderasib alone or with cetuximab and if people tolerate the treatments.
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT07209111) has an active research site in New Brunswick, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neoplasm malignant treatment options in New Brunswick, NJ, this clinical trial (NCT07209111) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neoplasm malignant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neoplasm malignant clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in New Brunswick — not just this study.
Browse Ankylosing Spondylitis Trials in New Brunswick →